Novartis AG ADR (NVS) Social Stream



Novartis AG ADR (NVS): $86.89

0.55 (+0.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NOVARTIS AG (NVS) Price Targets From Analysts

Use the tables below to see what analysts covering NOVARTIS AG think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 7 $108 $100 $104.333 $85.47 22.07%
2022-01-17 8 $105 $100 $102.666 $85.47 20.12%
2022-03-08 7 $105 $100 $103 $85.47 20.51%
2022-04-13 6 $105 $100 $103 $85.47 20.51%
2022-05-16 6 $106 $100 $103.666 $85.47 21.29%
2022-08-26 6 $105 $97 $101.666 $85.47 18.95%
2022-09-27 7 $105 $97 $101.666 $85.47 18.95%
2022-10-25 7 $105 $97 $101 $85.47 18.17%
2022-11-21 7 $105 $92 $99.333 $85.47 16.22%
2022-12-05 7 $105 $101 $102.666 $85.47 20.12%
2022-12-20 7 $107 $102 $104.666 $85.47 22.46%
2023-01-16 7 $108 $102 $105 $85.47 22.85%
2023-02-02 8 $108 $102 $105 $85.47 22.85%

The Trend in the Analyst Price Target


NVS's average price target has moved down $0.73 over the prior 29 months.

Over the past 51 weeks, NVS's average upside potential has been 22.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-26 6 105 97 101.666 82.68 22.96%
2022-09-10 7 105 97 101.666 82.60 23.08%
2022-10-25 7 105 97 101.000 78.51 28.65%
2023-01-16 7 108 102 105.000 91.06 15.31%
2023-01-26 8 108 102 105.000 89.84 16.87%

NVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 0 4 0 0 8

The Trend in the Broker Recommendations


Over the past 29 months, NVS's average broker recommendation rating worsened by 0.14.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVS as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, NOVARTIS AG's variance in analysts' estimates is lower than 7.48% of them.
  • In the context of stocks in the mega market cap category, NOVARTIS AG's number of analysts covering the stock is higher than 57.38% of them.
  • NVS has a greater average analyst price target than 1283.59% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NOVARTIS AG's upside potential (average analyst target price relative to current price) is higher than 274.71% of them.

Stocks similar to NOVARTIS AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABBV, MRK, and JNJ.

Is NVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7523 seconds.